Business

AI can help overcome both scientific and financial hurdles to tackle this serious threat to global health.

SiPhox’s coming silicon photonics technology seems to deliver on at least some of the promises Theranos made.

The maniacally focused founder of Insilico Medicine is going all in on AI to discover new medicines and extend lifespan.

As organ-on-a-chip technology comes of age, the bipartisan FDA Modernization Act 2.0 would remove the requirement that new drugs must undergo animal testing before human clinical trials.

A new wave of spit-and-swab home testing kits promises to give individuals more control over their own health.

Our writer unpacks the data behind the new vaccines and wonders what happened to nuance in the CDC’s recommendations.

How DeSci, DAOs, and NFTs will change research funding, intellectual property, and collaboration.

Workforce diversity, collective oversight, and day-to-day algorithm monitoring are all necessary to mitigate inherent bias.

Roswell Biotechnologies wants you to believe its new chip will revolutionize the detection of viruses, DNA, and more. But it still has to prove itself.

Microbiome research has huge implications for the very sick. But can startups get healthy people in on the action?